کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2006822 | 1066355 | 2010 | 4 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin](/preview/png/2006822.png)
Neuronostatin, a recently discovered peptide derived from the somatostatin preprohormone, significantly inhibited both food and water intake when administered centrally in adult male rats. Because neuronostatin is highly produced in the hypothalamus, an area of the brain through which important feeding circuits, including the central melanocortin system, communicate, we sought to determine if the anorexigenic and antidipsogenic effects of neuronostatin would be reversed by pretreatment with the melanocortin 3/4 receptor antagonist, SHU9119. SHU9119 pretreatment reversed the effect of neuronostatin on both food and water intake. We have shown recently that the central oxytocin system is a potential downstream mediator of the anorexignic action of alpha-MSH. We therefore tested whether the effects of neuronostatin also were dependent upon central oxytocin receptors. Neuronostatin-induced anorexia was not reversed by pretreatment with the oxytocin receptor antagonist, OVT, suggesting that neuronostatin acts through a unique subset of POMC neurons that do not signal via central oxytocin receptors.
Research highlights▶ Neuronostatin-induced anorexia and adipsia are reversed by Pretreatment with SHU9119. ▶ Pretreatment with OVT does not reverse the anorexigenic and antidipsogenic effects of neuronostatin.
Journal: Peptides - Volume 31, Issue 9, September 2010, Pages 1711–1714